Siobhan L Calhoun, MD
Obstetrics/Gynecology · Fremont
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 7
- 2 carriers
- Offices
- 2
- Since medical school
- 31 years
- Eastern Virginia Medical School, 1995
Offices
2 locations · Washington Township Medical Foundation · 125 clinicians in this group
Hospitals listed: Washington Hospital. That is not proof they admit you there this week.
Plans that list them
7 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Calhoun’s office at (510) 687-9510 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
7 of 7 plans
| Imperial Courage Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Dynamic Plan (HMO) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| Imperial Senior Value (HMO C-SNP) | Imperial Health Plan of California, Inc. | Listed | Sep 1, 2026 |
| SCAN Balance (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Classic (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN MyChoice (HMO) | SCAN Health Plan | Listed | Oct 3, 2026 |
| SCAN Strive (HMO C-SNP) | SCAN Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence A62859 · Current
Licensed to practise in California · since 1997 · expires 2027-04-30 · Eastern Virginia Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Obstetrics and Gynecology - Obstetrics and Gynecology
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Washington HospitalFremont, CAAcute Care Hospital · Government - Hospital District or Authority · Has an emergency department · Birthing-friendlyPart of Washington Hospital Healthcare SystemPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.188, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.164, Oct 2024 – Sep 2025
See every measure and the patient survey for Washington Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 5 the same, 0 worse of 7 measures. Readmissions: 1 better, 6 the same, 4 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.188 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.164 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.88 (0 to 1.88) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.92 (0.59 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.95 (139.54 to 246.36) · 48 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 7.4 · 164 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.1 · 199 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 8.9 · 463 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.6 · 661 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 9.3 · 174 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.7 · 2,550 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.15 (0 to 0.35) · 6,970 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.21 (0.02 to 0.4) · 7,108 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.82 (1.73 to 5.91) · 1,370 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.52 (0 to 3.17) · 589 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.75 (0.25 to 3.25) · 1,315 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 13.19 (5.83 to 20.56) · 600 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.91 (1.04 to 8.78) · 550 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.66 (0.17 to 3.14) · 198 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.14 (0 to 0.78) · 6,079 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 3.7 · 114 cases | None | Apr 2023 – Mar 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.367 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.8 · 186 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.9 · 480 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 33.9 · 186 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 26.5 · 553 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 36.8 · 648 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.5 · 590 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.7 (3.2 to 6.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 11.4 (8.5 to 14.9) · 169 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 130 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11.1 · 41 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.3 · 202 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.7 (10.2 to 18.5) · 78 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.1) · 974 cases | No different | Jan 2024 – Dec 2024 |
What patients said (812 patients answered, 19% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 76% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 56% |
| Yes, staff "did" give patients this information | 84% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 70% |
| Doctors "always" listened carefully | 76% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 70% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 86% |
| "Always" quiet at night | 46% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 42% |
| Yes, staff "did" give patients information about possible symptoms | 84% |
Original Medicare doctor bills
$6,179
Medicare paid this office $6,179 for 62 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Short return visit (20+ min) | 19 | $2,055 | $76 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 31 | $1,477 | $48 |
Procedures Medicare counted
| Skin biopsy | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Fitting and insertion of vaginal support device | – | – | 19 | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
62 Original Medicare patients in 2024. Average age 72 · Women 100% · Health risk score 1.02. Above the middle of the specialty; the typical obstetrics & gynecology clinician is at 0.88.
Conditions among them: High blood pressure 74% · Diabetes 35% · Chronic kidney disease 27% · Coronary heart disease 21%.
The office billed $19,641, Medicare allowed $8,049 and paid $6,179; for 148 services of 15 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 62 | 148 | 72 | 1.02 | $19,641 | $6,179 |
| 2023 | 75 | 175 | 73 | 0.84 | $24,930 | $7,950 |
| 2022 | 75 | 221 | 73 | 0.86 | $21,478 | $8,426 |
| 2021 | 57 | 95 | 72 | 0.83 | $13,695 | $5,378 |
| 2020 | 46 | 270 | 71 | 1.04 | $19,268 | $8,256 |
| 2019 | 56 | 107 | 70 | 0.74 | $18,523 | $7,335 |
| 2018 | 46 | 153 | 71 | 0.84 | $16,713 | $6,207 |
| 2017 | 55 | 234 | 69 | 0.91 | $20,974 | $8,020 |
| 2016 | 51 | 138 | 68 | 1.13 | $14,806 | $5,488 |
| 2015 | 53 | 91 | 68 | 0.84 | $18,480 | $7,052 |
| 2014 | 48 | 224 | 71 | 0.85 | $23,777 | $7,559 |
| 2013 | 41 | 133 | 71 | 0.82 | $8,885 | $3,832 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 2 services
| Short return visit (20+ min) | 25 | $2,666 | $76 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 33 | $1,560 | $47 |
2022: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 34 | $1,591 | $47 |
| Short return visit (20+ min) | 13 | $1,224 | $76 |
2021: 2 services
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 30 | $1,424 | $47 |
| Fitting and insertion of vaginal support device | 11 | $1,160 | $61 |
2020: 2 services
| Short return visit (20+ min) | 17 | $2,460 | $62 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 17 | $817 | $48 |
2019: 2 services
| Short return visit (20+ min) | 21 | $2,163 | $55 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 21 | $982 | $47 |
2018: 2 services
| Short return visit (20+ min) | 20 | $2,345 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 20 | $898 | $45 |
2017: 3 services
| Short return visit (20+ min) | 33 | $2,445 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 16 | $712 | $45 |
| Urinalysis, manual test | 15 | $48 | $3 |
2016: 2 services
| Short return visit (20+ min) | 20 | $1,448 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 13 | $540 | $42 |
2015: 2 services
| Short return visit (20+ min) | 24 | $1,671 | $58 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 12 | $511 | $43 |
2014: 3 services
| Short return visit (20+ min) | 24 | $1,824 | $57 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $600 | $43 |
| Urinalysis, manual test | 12 | $41 | $3 |
2013: 2 services
| Short return visit (20+ min) | 17 | $1,258 | $52 |
| Cervical or vaginal cancer screening; pelvic and clinical breast examination | 14 | $604 | $43 |
Drugs they prescribed that Part D paid
$10,881
Pharmacies billed $10,881 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 115) in 2024. At or below the middle of the specialty; the typical obstetrics & gynecology clinician is at 0%.
90 generic and 25 brand-name prescriptions · $10,881 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Estradiol | 30 | $1,596 | $53 |
| Fluconazole | 14 | $21 | $2 |
Year by year
| 2024 | 115 | 45 | 0% (0) | 22% | $10,881 |
| 2023 | 126 | 50 | None | 19% | $11,546 |
| 2022 | 80 | 40 | None | 19% | $7,914 |
| 2021 | 41 | 23 | 0% (0) | 41% | $7,421 |
| 2020 | 82 | 31 | 0% (0) | 17% | $9,739 |
| 2019 | 69 | 28 | 0% (0) | 35% | $11,823 |
| 2018 | 59 | 23 | 0% (0) | 31% | $9,186 |
| 2017 | 93 | 39 | None | 28% | $12,534 |
| 2016 | 78 | 27 | 0% (0) | 29% | $13,444 |
| 2015 | 74 | 27 | None | 58% | $15,823 |
| 2014 | 110 | 30 | None | 54% | $10,182 |
| 2013 | 88 | 23 | 0% (0) | 59% | $11,648 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 2 drugs
| Estradiol | 18 | $2,460 | $137 |
| Triamcinolone Acetonide | 13 | $118 | $9 |
2022: 1 drug
| Estradiol | 18 | $1,723 | $96 |
2021: 2 drugs
| Premarin | 13 | $4,689 | $361 |
| Estradiol | 11 | $1,813 | $165 |
2020: 2 drugs
| Premarin | 13 | $6,062 | $466 |
| Norethindrone | 11 | $278 | $25 |
2019: 3 drugs
| Premarin | 17 | $8,940 | $526 |
| Estradiol | 12 | $1,352 | $113 |
| Norethindrone | 13 | $175 | $13 |
2018: 2 drugs
| Premarin | 15 | $6,532 | $435 |
| Estradiol | 13 | $909 | $70 |
2017: 2 drugs
| Premarin | 22 | $8,224 | $374 |
| Estradiol | 15 | $74 | $5 |
2016: 2 drugs
| Premarin | 18 | $7,005 | $389 |
| Estrace | 13 | $3,493 | $269 |
2015: 1 drug
| Premarin | 13 | $2,697 | $207 |
2014: 3 drugs
| Premarin | 12 | $2,863 | $239 |
| Estradiol | 26 | $191 | $7 |
| Medroxyprogesterone Acetate | 18 | $159 | $9 |
2013: 2 drugs
| Premarin | 14 | $2,371 | $169 |
| Vagifem | 11 | $898 | $82 |
Money from drug and device companies
$51 in 2025
| 2025 | 2 | 2 | None | $51 |
| 2024 | 1 | 1 | None | $25 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
See all 2 published payments
| Pfizer | Meals · 2025-08-21 | Abrysvo | $27 |
| Organon | Meals · 2025-04-10 | None | $24 |
See earlier years (2024)
2024: $25
| Hologic Sales and Service | Acessa Provu System | $25 | 1 payment
|
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 86.9 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Professional record
- NPI
- 1396726295
- Licence
- CA A62859California A62859: Current · expires 2027-04-30
- Trained
- Eastern Virginia Medical School, 1995 · 31 years ago
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207V00000X (207V00000X)
- Mailing address
- 2299 Mowry Ave, #3c, Fremont, CA, 94538
- NPI first listed
- 2005-11-08
- NPI last updated
- 2007-07-08
This is when the NPI record was last certified, not a medical board exam.